๐ธContains only permissible ingredients and meets all ingredient-related requirements. ๐ธComplies with advertising, manufacturing, and GMP standards. ๐ธHas written agreements with all nominated manufacturers. ๐ธIncludes only approved indications and claims, with supporting evidence. ๐ธDoes not contain prohibited substances or imports. ๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป ๐ฃ๐ฟ๐ผ๐ฐ๐ฒ๐๐ Sponsors use the TGA Business Services portal to: ๐ธEnter product details.
๐ธReceive an AUST L or AUST L(A) number and certificate. ๐ฃ๐ผ๐๐-๐๐ถ๐๐๐ถ๐ป๐ด ๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ถ๐ฏ๐ถ๐น๐ถ๐๐ถ๐ฒ๐ Once listed, sponsors must: ๐ธMaintain pharmacovigilance records and report adverse events.
| Advice | Explanation |
|---|---|
| Avoid alcohol | Can decrease effectiveness or increase side effects |
| Do not take with fatty meals | May delay absorption |
| Report adverse effects | Seek medical attention for prolonged erection or vision changes |
| Follow prescribed dose | Do not alter dose without consulting healthcare professional |
๐ธComply with any ingredient-specific conditions (e.g., standards for Ginkgo biloba). ๐ธNotify the TGA of overseas recalls or safety issues. ๐ ๐ฎ๐ธ๐ถ๐ป๐ด ๐๐ต๐ฎ๐ป๐ด๐ฒ๐ Sponsors may request changes to their ARTG entry to: ๐ธCorrect errors.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Generic | 60mg | 120 + 8 Pills | 372.33โฌ 354.60โฌ | |
| Levitra Generic | 40mg | 90 + 6 Pills | 234.73โฌ 223.55โฌ | |
| Levitra Soft Tabs | 20mg | 270 + 10 Pills | 521.78โฌ 496.93โฌ | |
| Levitra Original | 20mg | 22 + 2 Pills | 138.55โฌ 131.95โฌ | |
| Levitra Original | 20mg | 76 + 4 Pills | 344.39โฌ 327.99โฌ | |
| Levitra Original | 20mg | 48 + 4 Pills | 235.14โฌ 223.94โฌ | |
| Levitra Generic | 60mg | 20 Pills | 81.30โฌ 77.43โฌ | |
| Levitra Generic | 60mg | 10 Pills | 47.42โฌ 45.16โฌ | |
| Levitra Generic | 60mg | 90 + 6 Pills | 291.82โฌ 277.92โฌ | |
| Levitra Generic | 40mg | 60 + 4 Pills | 162.37โฌ 154.64โฌ |
๐ธSome changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the โGroups Order.โ ๐ง๐ต๐ฎ๐ป๐ธ ๐๐ผ๐ ๐ for ๐๐ผ๐๐ฟ time and please ๐๐ถ๐ธ๐ฒ ๐, ๐ฆ๐ต๐ฎ๐ฟ๐ฒ, and/or ๐๐ผ๐บ๐บ๐ฒ๐ป๐ #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ๐๐จ๐ป๐ฑ๐ฒ๐ฟ๐๐๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐๐ต๐ฒ ๐น๐ฒ๐ด๐ถ๐๐น๐ฎ๐๐ถ๐๐ฒ ๐ณ๐ฟ๐ฎ๐บ๐ฒ๐๐ผ๐ฟ๐ธ ๐ณ๐ผ๐ฟ ๐น๐ถ๐๐๐ฒ๐ฑ ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ๐ This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). ๐ธSome changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the โGroups Order.โ ๐ง๐ต๐ฎ๐ป๐ธ ๐๐ผ๐ ๐ for ๐๐ผ๐๐ฟ time and please ๐๐ถ๐ธ๐ฒ ๐, ๐ฆ๐ต๐ฎ๐ฟ๐ฒ, and/or ๐๐ผ๐บ๐บ๐ฒ๐ป๐ #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug cost levitra uk inspectors to immediately seize the affected products from markets across the country. According to a statement issued on Wednesday, the counterfeit medicines identified are Efaston tablets (Dydrogesterone 10mg) and Paracare suspension 60ml (Paracetamol 120mg/5ml). Laboratory analysis revealed that both products lack active pharmaceutical ingredients, rendering them ineffective and unsafe for public use.
DRAP warned that such falsified drugs pose a serious threat to public health, potentially leading to treatment failure, worsening of illness, or life-threatening complications particularly for patients relying on them for essential therapies. The authority has advised citizens to stop using these products immediately and to consult healthcare professionals if they experience any adverse effects. Consumers have also been urged to verify batch numbers before purchasing medicines and to report suspicious products to local health authorities. In addition, pharmacies, hospitals, and healthcare providers have been instructed to monitor their supply chains closely and report any quality or safety concerns related to the two medicines to DRAP without delay. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country.
#DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in ๐จ ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ฉ๐๐๐ญ๐ - ๐๐๐๐ฅ๐๐ง๐: ๐๐ฎ๐ข๐๐๐ง๐๐ ๐จ๐ง ๐๐๐๐๐ญ๐ฒ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง (๐๐ฉ๐๐๐ญ๐๐ ๐๐ ๐๐๐ญ๐จ๐๐๐ซ ๐๐๐๐) ๐ ๐๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ โ Clear definition of electronic distribution and what constitutes electronic dissemination of safety information (Section: Dissemination of Safety Information) โ Clarification that safety information related to pharmaceutical forms not marketed in Iceland will not be assessed by the Icelandic Medicines Agency (Section: 1.6 Review by the Icelandic Medicines Agency and Dissemination of Safety Information) โ Aimed at strengthening regulatory transparency and consistency in safety information handling ๐๐ก๐ฒ ๐๐ญ ๐๐๐ญ๐ญ๐๐ซ๐ฌ This update enhances efficiency and clarity in the regulatory process, ensuring streamlined communication and compliance for Marketing Authorization Holders (MAHs) operating within Iceland. It reinforces a transparent and harmonized approach to safety information management. ๐ At Viginovix, we continuously monitor global pharmacovigilance and regulatory updates to help our partners uphold compliance, safety excellence, and readiness across all regions. ๐ฉ info@viginovix.com & awanishpandey@viginovix.com ๐ ๐ What are your thoughts on how local regulatory clarifications contribute to global pharmacovigilance harmonization?
#RegulatoryUpdate #Pharmacovigilance #DrugSafety #RegulatoryAffairs #Viginovix To view or add a comment, sign in ๐จ ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ฉ๐๐๐ญ๐ - ๐๐๐๐ฅ๐๐ง๐: ๐๐ฎ๐ข๐๐๐ง๐๐ ๐จ๐ง ๐๐๐๐๐ญ๐ฒ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง (๐๐ฉ๐๐๐ญ๐๐ ๐๐ ๐๐๐ญ๐จ๐๐๐ซ ๐๐๐๐) ๐ ๐๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. To view or add a comment, sign in Here's a comprehensive overview of the significance of various regulatory bodies, quality standards, and research methodologies in the pharmaceutical industry: Regulatory Bodies 1- USFDA (United States Food and Drug Administration) Ensures the safety and efficacy of drugs, biologics, and medical devices in the US. USFDA approval is considered a gold standard for pharmaceutical products globally. 2- UK MHRA (Medicines and Healthcare products Regulatory Agency) Regulates medicines and medical devices in the UK, ensuring their safety, quality, and efficacy. 3- FSSAI (Food Safety and Standards Authority of India) Regulates food safety and standards in India, ensuring the quality and safety of food products. DRAP warned that such falsified drugs pose a serious threat to public health, potentially leading to treatment failure, worsening of illness, or life-threatening complications particularly for patients relying on them for essential therapies. The authority has advised citizens to stop using these products immediately and to consult healthcare professionals if they experience any adverse effects.
Consumers have also been urged to verify batch numbers before purchasing medicines and to report suspicious products to local health authorities. In addition, pharmacies, hospitals, and healthcare providers have been instructed to monitor their supply chains closely and report any quality or safety concerns related to the two medicines to DRAP without delay. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in ๐จ ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ฉ๐๐๐ญ๐ - ๐๐๐๐ฅ๐๐ง๐: ๐๐ฎ๐ข๐๐๐ง๐๐ ๐จ๐ง ๐๐๐๐๐ญ๐ฒ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง (๐๐ฉ๐๐๐ญ๐๐ ๐๐ ๐๐๐ญ๐จ๐๐๐ซ ๐๐๐๐) ๐ ๐๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ โ Clear definition of electronic distribution and what constitutes electronic dissemination of safety information (Section: Dissemination of Safety Information) โ Clarification that safety information related to pharmaceutical forms not marketed in Iceland will not be assessed by the Icelandic Medicines Agency (Section: 1.6 Review by the Icelandic Medicines Agency and Dissemination of Safety Information) โ Aimed at strengthening regulatory transparency and consistency in safety information handling ๐๐ก๐ฒ ๐๐ญ ๐๐๐ญ๐ญ๐๐ซ๐ฌ This update enhances efficiency and clarity in the regulatory process, ensuring streamlined communication and compliance for Marketing Authorization Holders (MAHs) operating within Iceland. It reinforces a transparent and harmonized approach to safety information management. ๐ At Viginovix, we continuously monitor global pharmacovigilance and regulatory updates to help our partners uphold compliance, safety excellence, and readiness across all regions. ๐ฉ info@viginovix.com & awanishpandey@viginovix.com ๐ ๐ What are your thoughts on how local regulatory clarifications contribute to global pharmacovigilance harmonization?
#RegulatoryUpdate #Pharmacovigilance #DrugSafety #RegulatoryAffairs #Viginovix To view or add a comment, sign in ๐จ ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ฉ๐๐๐ญ๐ - ๐๐๐๐ฅ๐๐ง๐: ๐๐ฎ๐ข๐๐๐ง๐๐ ๐จ๐ง ๐๐๐๐๐ญ๐ฒ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง (๐๐ฉ๐๐๐ญ๐๐ ๐๐ ๐๐๐ญ๐จ๐๐๐ซ ๐๐๐๐) ๐ ๐๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. To view or add a comment, sign in Here's a comprehensive overview of the significance of various regulatory bodies, quality standards, and research methodologies in the pharmaceutical industry: Regulatory Bodies 1- USFDA (United States Food and Drug Administration) Ensures the safety and efficacy of drugs, biologics, and medical devices in the US.
Quality Standards 1- GMP (Good Manufacturing Practice) A set of guidelines ensuring pharmaceutical products are manufactured, tested, and packaged in a controlled environment to meet quality standards. 2- ISO 9000 A series of quality management standards that help organizations ensure their products or services meet customer and regulatory requirements. Research Methodologies 1- Double-blind placebo-controlled studies A research design where participants are randomly assigned to treatment or placebo groups, and both participants and researchers are blinded online levitra sale to the treatment assignments. This design helps minimize bias and ensures the reliability of results. 2- Case trials studies Also known as clinical trials, these studies evaluate the safety and efficacy of new treatments or interventions in humans.
3- Black box symbol A warning label required by regulatory agencies, such as the USFDA, to highlight serious or life-threatening risks associated with a particular medication. Intellectual Property and Standards 1- IP (Intellectual Property) Refers to patents, trademarks, copyrights, and trade secrets that protect innovations and creations in the pharmaceutical industry. 2- USP (United States Pharmacopeia) A non-profit organization that sets standards for the quality, purity, and identity of medicines, food ingredients, and dietary supplements. Journals and Publications 1- Peer-reviewed journals Scientific publications that publish research articles after rigorous review by experts in the field, ensuring the quality and validity of the research. 2-These regulatory bodies, quality standards, and research methodologies play a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products and medical devices.
By adhering to these standards and guidelines, pharmaceutical companies. #pharmaregulatorycompliance# #pharmaqualityconyrolmeasures# #goodsmanufacturingpractices# #pharmanutraceuticals# To view or add a comment, sign in Here's a comprehensive overview of the significance of various regulatory bodies, quality standards, and research methodologies in the pharmaceutical industry: Regulatory Bodies 1- USFDA (United States Food and Drug Administration) Ensures the safety and efficacy of drugs, biologics, and medical devices in the US. To view or add a comment, sign in Drug regulator tightens safety norms after cough syrup deaths Following the death of 23 children in Madhya Pradesh due to consumption of Coldrif cough syrup contaminated with diethylene glycol (DEG), the Drugs Controller General of India (DCGI) mandated mandatory testing for both DEG and ethylene glycol (EG) in all raw materials and finished pharmaceutical products. Previously, such tests were only required for raw materials, leaving finished syrups vulnerable to contamination. This regulatory change was prompted by a request from the Madhya Pradesh Food and Drugs Administration (MPFDA), which urged the inclusion of DEG and EG testing in the general monograph of the Indian Pharmacopoeia (IP). USFDA approval is considered a gold standard for pharmaceutical products globally. 2- UK MHRA (Medicines and Healthcare products Regulatory Agency) Regulates medicines and medical devices in the UK, ensuring their safety, quality, and efficacy. 3- FSSAI (Food Safety and Standards Authority of India) Regulates food safety and standards in India, ensuring the quality and safety of food products. Quality Standards 1- GMP (Good Manufacturing Practice) A set of guidelines ensuring pharmaceutical products are manufactured, tested, and packaged in a controlled environment to meet quality standards. 2- ISO 9000 A series of quality management standards that help organizations ensure their products or services meet customer and regulatory requirements. Research Methodologies 1- Double-blind placebo-controlled studies A research design where participants are randomly assigned to treatment or placebo groups, and both participants and researchers are blinded online levitra sale to the treatment assignments. This design helps minimize bias and ensures the reliability of results. 2- Case trials studies Also known as clinical trials, these studies evaluate the safety and efficacy of new treatments or interventions in humans. 3- Black box symbol A warning label required by regulatory agencies, such as the USFDA, to highlight serious or life-threatening risks associated with a particular medication.
Intellectual Property and Standards 1- IP (Intellectual Property) Refers to patents, trademarks, copyrights, and trade secrets that protect innovations and creations in the pharmaceutical industry.
๐ธContains only permissible ingredients and meets all ingredient-related requirements. ๐ธComplies with advertising, manufacturing, and GMP standards. ๐ธHas written agreements with all nominated manufacturers. ๐ธIncludes only approved indications and claims, with supporting evidence. ๐ธDoes not contain prohibited substances or imports.
๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป ๐ฃ๐ฟ๐ผ๐ฐ๐ฒ๐๐ Sponsors use the TGA Business Services portal to: ๐ธEnter product details. ๐ธReceive an AUST L or AUST L(A) number and certificate. ๐ฃ๐ผ๐๐-๐๐ถ๐๐๐ถ๐ป๐ด ๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ถ๐ฏ๐ถ๐น๐ถ๐๐ถ๐ฒ๐ Once listed, sponsors must: ๐ธMaintain pharmacovigilance records and report adverse events. ๐ธComply with any ingredient-specific conditions (e.g., standards for Ginkgo biloba). ๐ธNotify the TGA of overseas recalls or safety issues.
๐ ๐ฎ๐ธ๐ถ๐ป๐ด ๐๐ต๐ฎ๐ป๐ด๐ฒ๐ Sponsors may request changes to their ARTG entry to: ๐ธCorrect errors. ๐ธSome changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the โGroups Order.โ ๐ง๐ต๐ฎ๐ป๐ธ ๐๐ผ๐ ๐ for ๐๐ผ๐๐ฟ time and please ๐๐ถ๐ธ๐ฒ ๐, ๐ฆ๐ต๐ฎ๐ฟ๐ฒ, and/or ๐๐ผ๐บ๐บ๐ฒ๐ป๐ #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ๐๐จ๐ป๐ฑ๐ฒ๐ฟ๐๐๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐๐ต๐ฒ ๐น๐ฒ๐ด๐ถ๐๐น๐ฎ๐๐ถ๐๐ฒ ๐ณ๐ฟ๐ฎ๐บ๐ฒ๐๐ผ๐ฟ๐ธ ๐ณ๐ผ๐ฟ ๐น๐ถ๐๐๐ฒ๐ฑ ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ๐ This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). ๐ธSome changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the โGroups Order.โ ๐ง๐ต๐ฎ๐ป๐ธ ๐๐ผ๐ ๐ for ๐๐ผ๐๐ฟ time and please ๐๐ถ๐ธ๐ฒ ๐, ๐ฆ๐ต๐ฎ๐ฟ๐ฒ, and/or ๐๐ผ๐บ๐บ๐ฒ๐ป๐ #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug cost levitra uk inspectors to immediately seize the affected products from markets across the country. According to a statement issued on Wednesday, the counterfeit medicines identified are Efaston tablets (Dydrogesterone 10mg) and Paracare suspension 60ml (Paracetamol 120mg/5ml). Laboratory analysis revealed that both products lack active pharmaceutical ingredients, rendering them ineffective and unsafe for public use. 2- USP (United States Pharmacopeia) A non-profit organization that sets standards for the quality, purity, and identity of medicines, food ingredients, and dietary supplements. Journals and Publications 1- Peer-reviewed journals Scientific publications that publish research articles after rigorous review by experts in the field, ensuring the quality and validity of the research. 2-These regulatory bodies, quality standards, and research methodologies play a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products and medical devices.
In response, DCGI directed the Indian Pharmacopoeia Commission (IPC) to act immediately, leading to the issuance of โAmendment List-09โ to IP 2022. This amendment enforces mandatory DEG and EG testing for all oral liquid formulations, with permissible limits not exceeding 0.10%. The quantity must be measured using gas chromatography. The IPC also circulated the directive across India to relevant drug control authorities, laboratories, and pharmaceutical industry associations to ensure prompt implementation. This regulatory update addresses a critical loophole exposed by the repeated cough syrup-related deaths and aims to enhance drug safety and restore public trust in India's pharmaceutical regulatory framework.
By adhering to these standards and guidelines, pharmaceutical companies. #pharmaregulatorycompliance# #pharmaqualityconyrolmeasures# #goodsmanufacturingpractices# #pharmanutraceuticals# To view or add a comment, sign in Here's a comprehensive overview of the significance of various regulatory bodies, quality standards, and research methodologies in the pharmaceutical industry: Regulatory Bodies 1- USFDA (United States Food and Drug Administration) Ensures the safety and efficacy of drugs, biologics, and medical devices in the US. To view or add a comment, sign in Drug regulator tightens safety norms after cough syrup deaths Following the death of 23 children in Madhya Pradesh due to consumption of Coldrif cough syrup contaminated with diethylene glycol (DEG), the Drugs Controller General of India (DCGI) mandated mandatory testing for both DEG and ethylene glycol (EG) in all raw materials and finished pharmaceutical products. Previously, such tests were only required for raw materials, leaving finished syrups vulnerable to contamination. This regulatory change was prompted by a request from the Madhya Pradesh Food and Drugs Administration (MPFDA), which urged the inclusion of DEG and EG testing in the general monograph of the Indian Pharmacopoeia (IP). In response, DCGI directed the Indian Pharmacopoeia Commission (IPC) to act immediately, leading to the issuance of โAmendment List-09โ to IP 2022. This amendment enforces mandatory DEG and EG testing for all oral liquid formulations, with permissible limits not exceeding 0.10%. The quantity must be measured using gas chromatography. The IPC also circulated the directive across India to relevant drug control authorities, laboratories, and pharmaceutical industry associations to ensure prompt implementation.
This regulatory update addresses a critical loophole exposed by the repeated cough syrup-related deaths and aims to enhance drug safety and restore public trust in India's pharmaceutical regulatory framework.